title: The tobacco-dependence clinic: intensive tobacco-dependence treatment in an addiction services outpatient setting.
abstract: We present outcomes from an intensive tobacco-dependence treatment program for addiction services clients at three different sites. Data from 202 participants were analyzed. For individuals who completed the program, the abstinence rate was 43%. Not having a primary substance use history and a lower carbon monoxide (CO) level at intake predicted abstinence; whereas being female, the particular site of intervention, receiving both nicotine replacement therapy (NRT) and oral medication, and having a lower CO level at baseline predicted program completion. Drug treatment clients can successfully quit smoking at rates similar to the general population when given access to intensive tobacco-dependence treatment.
authors.affiliation: Vancouver Costal Health Tobacco Dependence Clinic, Vancouver, British Columbia, Canada.
authors.forename: Milan
authors.initials: M
authors.lastname: Khara
authors.forename: Chizimuzo T C
authors.initials: CT
authors.lastname: Okoli
mesh_terms: D000554:Ambulatory Care Facilities / Q000706:statistics & numerical data*; D016642:Bupropion / Q000627:therapeutic use*; D003376:Counseling / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D018722:Nicotinic Agonists / Q000627:therapeutic use*; D010349:Patient Compliance / Q000706:statistics & numerical data; D010865:Pilot Projects; D012307:Risk Factors; D016540:Smoking Cessation / Q000379:methods / Q000706:statistics & numerical data*; D016320:Substance Abuse Treatment Centers / Q000706:statistics & numerical data*; D014029:Tobacco Use Disorder / Q000188:drug therapy* / Q000628:therapy*
chemical_list: D018722:Nicotinic Agonists; D016642:Bupropion